ARCH Cost, Cost-Effectiveness, and Health-Economic Implications
Deep-dive into cost-effectiveness analyses derived from the ARCH trial comparing romosozumab to alendronate, including cost per QALY, payer coverage, and individual value calculations.
Trials Arch
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
8articles
4topic areas covered
May 25, 2026latest review
Trials Arch library
Showing 8 of 8 clinical reviews.
ARCH Extension Data and What Happened After the Trial Ended
What became of romosozumab's fracture benefits after the ARCH trial closed? This deep-dive covers durability data, bone density trajectories, late cardiovascular safety signals, and what sequential therapy evidence tells us about long-term outcomes.
ARCH Results in Detail: Numbers, Subgroups, and Time Course
A deep dive into the ARCH trial's primary and secondary endpoints for romosozumab vs alendronate, including effect sizes, confidence intervals, time-course data, and subgroup analyses.
ARCH Subgroup Analyses: Who Responded Most and Least to Romosozumab vs Alendronate
Deep-dive into ARCH trial pre-specified and post-hoc subgroup analyses examining romosozumab efficacy by age, BMI, baseline T-score, prior fracture status, and bone turnover markers.
ARCH Trial: A Plain-English Overview of What It Established
A deep-dive into the ARCH trial (2017), which compared romosozumab to alendronate in postmenopausal women with osteoporosis and prior fracture, showing a 48% reduction in new vertebral fractures.
Honest Criticisms and Limitations of the ARCH Trial
A critical appraisal of the ARCH trial (romosozumab vs alendronate) covering enrollment biases, cardiovascular safety signals, follow-up gaps, generalizability concerns, and conflict-of-interest disclosures.
Inside the ARCH Methodology: What Most Summaries Skip
A deep-dive into the ARCH trial's design choices, from randomization and blinding to the comparator rationale and statistical framework, and how each decision shapes the clinical interpretation of romosozumab vs alendronate.
What ARCH Actually Changes in Clinical Practice
How the ARCH trial reshaped osteoporosis treatment sequencing, guideline updates, and real-world prescribing of romosozumab for high-fracture-risk patients.